MEETING ON MOLECULAR BASIS OF TUMOR IMMUNOLOGY
MEETING ON MOLECULAR BASIS OF TUMOR IMMUNOLOGY
批准号:
3434127
负责人:
ELLEN S VITETTA
金额:
$0.6万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-15 至 1991-04-14
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Support is requested for a scientific meeting organized by the American
Association for Cancer Research, Inc. (AACR). The conference is entitled
"Molecular Basis of Tumor Immunology" and will be held at the Sheraton
Reston Hotel in Reston, Virginia, on May 20-22, 1990. The Organizing
Committee for this conference consists of Drs. Tak W. Mak, Chairperson;
Lloyd J. Old; and Ellen S. Vitetta, Principal Investigator. Twenty
scientific leaders in the fields of molecular biology, molecular
immunology, and tumor immunology will make presentations aimed at
producing not only a better understanding of the evolution of tumor
development, but also the eventual control of growth malignant cells.
Approximately 150 other participants will have the opportunity to present
their own work during a poster session. It is anticipated that this
exchange of ideas between molecular immunologists and oncologists will
produce new approaches and experiments that will lead to the containment
of neoplastic evolution through manipulation of the immune cells and
their products.
Recent studies of immunoglobulin genes, T-cell receptor genes, the
processing of antigens, MHC genes, and T-lymphocytes have supported the
hypothesis that the immune system and its genes may be involved in the
regulation of neoplastic growth. Previous scientific meetings have
concentrated on one or two of the scientific areas described above. Our
proposal is to focus on all the molecular aspects of immune recognition
pertaining to neoplastic genesis and growth.
Participants will be drawn from all relevant scientific areas and all
levels of training, from graduate students to senior scientists or
physicians. The resulting exchange of information should produce
valuable new leads for both the laboratory and the clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel vaccine to prevent HCV infection and hence liver cancer
-
批准号:7943947
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2009
-
负责人:ELLEN S VITETTA
-
依托单位:
A novel vaccine to prevent HCV infection and hence liver cancer
-
批准号:7852639
-
项目类别:
-
资助金额:$68.37万
-
财政年份:2009
-
负责人:ELLEN S VITETTA
-
依托单位:
PHASE 1 STUDY OF SAFETY & IMMUNOGENICITY OF AN ALUM-FORMULATED RECOMBINANT RICIN
-
批准号:7475286
-
项目类别:
-
资助金额:$32.17万
-
财政年份:2007
-
负责人:ELLEN S VITETTA
-
依托单位:
PHASE 1 STUDY OF SAFETY & IMMUNOGENICITY OF AN ALUM-FORMULATED RECOMBINANT RICIN
-
批准号:7213715
-
项目类别:
-
资助金额:$30.77万
-
财政年份:2007
-
负责人:ELLEN S VITETTA
-
依托单位:
PHASE 1 STUDY OF SAFETY & IMMUNOGENICITY OF AN ALUM-FORMULATED RECOMBINANT RICIN
-
批准号:7623849
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2007
-
负责人:ELLEN S VITETTA
-
依托单位:
Development of a lyophilized intradermal/intranasal ricin vaccine
-
批准号:7133314
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2006
-
负责人:ELLEN S VITETTA
-
依托单位:
Development of a lyophilized intradermal/intranasal ricin vaccine
-
批准号:7255730
-
项目类别:
-
资助金额:$58.83万
-
财政年份:2006
-
负责人:ELLEN S VITETTA
-
依托单位:
Development of a lyophilized intradermal/intranasal ricin vaccine
-
批准号:7446146
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2006
-
负责人:ELLEN S VITETTA
-
依托单位:
Development of a lyophilized intradermal/intranasal ricin vaccine
-
批准号:7643996
-
项目类别:
-
资助金额:$54.03万
-
财政年份:2006
-
负责人:ELLEN S VITETTA
-
依托单位:
Development of a lyophilized intradermal/intranasal ricin vaccine
-
批准号:7871434
-
项目类别:
-
资助金额:$73.51万
-
财政年份:2006
-
负责人:ELLEN S VITETTA
-
依托单位:
IMMUNOTOXIN-DEPLETION OF HIV-1+ T CELLS
-
批准号:7165197
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2005
-
负责人:ELLEN S VITETTA
-
依托单位:
The reversal of multidrug resistance by an anti-CD19 ab.
-
批准号:6892860
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2004
-
负责人:ELLEN S VITETTA
-
依托单位:
IMMUNOTOXIN-DEPLETION OF HIV-1+ T CELLS
-
批准号:6970631
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2004
-
负责人:ELLEN S VITETTA
-
依托单位:
The reversal of multidrug resistance by an anti-CD19 ab.
-
批准号:6703394
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2004
-
负责人:ELLEN S VITETTA
-
依托单位:
The reversal of multidrug resistance by an anti-CD19 ab.
-
批准号:7060397
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2004
-
负责人:ELLEN S VITETTA
-
依托单位:
A Novel Recombinant Protein Vaccine Against Ricin Toxin
-
批准号:6796651
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2003
-
负责人:ELLEN S VITETTA
-
依托单位:
A Novel Recombinant Protein Vaccine Against Ricin Toxin
-
批准号:6862775
-
项目类别:
-
资助金额:$67.88万
-
财政年份:2003
-
负责人:ELLEN S VITETTA
-
依托单位:
A Novel Recombinant Protein Vaccine Against Ricin Toxin
-
批准号:7019153
-
项目类别:
-
资助金额:$60.5万
-
财政年份:2003
-
负责人:ELLEN S VITETTA
-
依托单位:
A Novel Recombinant Protein Vaccine Against Ricin Toxin
-
批准号:6681436
-
项目类别:
-
资助金额:$63.59万
-
财政年份:2003
-
负责人:ELLEN S VITETTA
-
依托单位:
IMMUNOTOXIN-DEPLETION OF HIV-1+T CELLS
-
批准号:6632422
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2001
-
负责人:ELLEN S VITETTA
-
依托单位:
海外基金